{
    "url_original": "https://www.wsj.com/articles/fda-moving-to-authorize-pfizer-biontech-booster-for-16-17-year-olds-11638233782",
    "url": "fda-moving-to-authorize-pfizer-biontech-booster-for-16-17-year-olds-11638233782",
    "title": "FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds",
    "sub_head": "The agency could clear use of the extra doses as soon as next week as concerns rise over Omicron variant",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-442905?width=860&height=573",
    "image_1": "im-442905.jpg",
    "time": "2021-11-29 20:05:00",
    "body": "The Food and Drug Administration could authorize Covid-19 boosters from  Pfizer Inc.  and  BioNTech SE  for use in 16- and 17-year olds as soon as next week as concerns rise over a new, possibly more transmissible variant, according to a person familiar with the planning.<br />The agency is planning to move rapidly to take action on a request by the companies to authorize boosters for 16- and-17 year olds, according to a person familiar with the matter. So far, only people 18 years and older are eligible for boosters."
}